GoodRx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced its participation in two upcoming investor conferences. The company's executives will engage in fireside chats at:

• The Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 5, 2024, at 7:45 a.m. ET
• The Wells Fargo 2024 Healthcare Conference in Boston, MA on September 6, 2024, at 8:00 a.m. ET

Both events will be livestreamed on GoodRx's Investor Relations website, with archived recordings available for at least 30 days after each conference.

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences:

• Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Thursday, September 5, 2024 at 7:45 a.m. Eastern Time (4:45 a.m. Pacific Time)
• Wells Fargo 2024 Healthcare Conference in Boston, MA on Friday, September 6, 2024 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time)

A live webcast of each of the foregoing events will be available on the Company's Investor Relations website, https://investors.goodrx.com/. Following each conference, an archived recording will be available on the Company’s website for at least 30 days.

About GoodRx

GoodRx is the leading prescription savings platform in the U.S. Trusted by more than 25 million consumers and 750,000 healthcare professionals annually, GoodRx provides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save nearly $75 billion on the cost of their prescriptions.

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240821557898/en/

Investor Contact

GoodRx

Aubrey Reynolds

ir@goodrx.com

Press Contact

GoodRx

Lauren Casparis

lcasparis@goodrx.com

Source: GoodRx Holdings, Inc.

FAQ

When is GoodRx (GDRX) participating in the Morgan Stanley Healthcare Conference?

GoodRx (GDRX) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 7:45 a.m. Eastern Time in New York, NY.

What investor conference is GoodRx (GDRX) attending in Boston?

GoodRx (GDRX) is attending the Wells Fargo 2024 Healthcare Conference in Boston, MA on Friday, September 6, 2024, at 8:00 a.m. Eastern Time.

How can investors watch GoodRx's (GDRX) presentations at these conferences?

Investors can watch live webcasts of GoodRx's (GDRX) presentations on the company's Investor Relations website, https://investors.goodrx.com/. Archived recordings will be available for at least 30 days after each conference.

What type of events will GoodRx (GDRX) executives participate in at these conferences?

GoodRx (GDRX) executives will participate in fireside chats at both the Morgan Stanley and Wells Fargo healthcare conferences in September 2024.